(2R)-1-[(1R)-1-[Bis-tert-butylphosphino]ethyl]-2-(diphenylphosphino)ferrocene>98.0%(HPLC)200mg

5-(Cyclopropylmethyl)-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 100mg

Indium foil 99.995% 0.05 x 25 x 25 mm 1 pc

N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)butyramide, 98%, 1mg

4-((6-Chloro-3-(4-chloro-2-fluorobenzyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)methyl)morpholine, 98%, 250mg

3-Nitrophenacyl bromide, 95.0%, 50g

N-methyl-1-(1-methyl-1H-benzimidazol-2-yl)methanamine dihydrochloride, 95.0%, 1g

Chloromethylmethyldiethoxysilane, 95%, 1g

4-Chloro-7-methoxy-2-phenylquinoline, 98.0%, 5g

Oritavancin diphosphate, 99.67%, 100mg

Ethyl 4-(benzyl(2-ethoxy-2-oxoethyl)amino)butanoate, 95.0%, 1g

5-(Piperidin-4-yl)-2-(trifluoromethyl)pyridine hydrochloride, 97%, 1g

N,N-Diethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanamine, 95.0%, 1g